MagForce

MagForce AG, a medical device company, operates in the field of nanotechnology-based cancer treatment in Germany. The company offers NanoTherm therapy that treats solid tumors through the intratumoral generation of heat by activating superparamagnetic nanoparticles. It also provides NanoTherm, a ferrofluid liquid containing superparamagnetic iron oxide nanopracticles that is activated in an alternating magnetic field; NanoPlan, a treatment planning software; and NanoActivator, a magnetic field applicator for therapy. The company was founded in 1997 and is headquartered in Berlin, Germany.

Type
Public
HQ
Berlin, DE
Founded
1997
Employees
29 (est)+4%
MagForce was founded in 1997 and is headquartered in Berlin, DE

Key People at MagForce

Ben J. Lipps

Ben J. Lipps

CEO
Hoda Tawfik

Hoda Tawfik

COO

MagForce Locations

Berlin, DE
Planegg, DE

MagForce Metrics

MagForce Summary

Market capitalization

€123 M

Closing share price

€4.85
MagForce's latest market capitalization is €123 M.

MagForce Market Value History

MagForce Company Life

You may also be interested in